Mentioned:
One of the boldest investors in drug discovery and digital assets is making a bet on something new: a copper project in Chile.
What’s happening:
- Entrepreneur and investor Christian Angermayer has made a strategic investment of $1M CAD into Super Copper (CSE: CUPR) through his family office Apeiron Investments
Why it matters:
- Christian Angermayer is the co-founder of publicly traded psychedelic drug development companies atai Life Sciences (NASDAQ: ATAI) and Compass Pathways (NASDAQ: CMPS) and was also a notable early investor in Bitcoin
Going deeper:
- Super Copper’s flagship copper project Cordillera Cobre is located in the historic Atacama Province in Chile, which has previously produced large scale copper discoveries owned by mining giants including Lundin Mining (TSX: LUN) and BHP (NYSE: BHP)
- Super Copper’s initial rock sampling at Cordillera Cobrea has seen early validation of high grades of copper, with 46 out of 122 rock grab samples returning 1.0% copper mineralization
The intrigue:
- Super Copper is also currently developing a proprietary biopolymer technology in partnership with Canadian reagent solutions company MetaFLO to enhance the efficiency of copper processing and also reduce the environmental impact of copper extraction
